California launches massive data drive to transform early psychosis treatment

NCT ID NCT04007510

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: University of California, Davis Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study aims to create a network of clinics across California that use a mobile app to collect data from people with early psychosis and their families. The data will help doctors track symptoms and make better treatment decisions. Researchers will also develop a tool to measure how long psychosis goes untreated, which may improve early intervention. Over 1,300 participants will be followed for up to two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: mHealth app and DUP assessment tool
What this could lead to: If successful, this could create a model for using real-world data to improve treatment planning and outcomes for people with early psychosis.
What could go wrong: This is an observational, data-gathering study, not a treatment trial. It may not directly improve symptoms, and the tools developed may not work well in all community clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FIRST EPISODE PSYCHOSIS (FEP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychotic Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FIRST EPISODE PSYCHOSIS (FEP)

Contacts and locations

Locations

Imaging Research Center

Sacramento, California, 95817, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.